EuBiologics

206650 · KOSDAQ · Health Care · SMALL CAP

Updated contract terms.

EuBiologics updated a previously disclosed supply contract with UNICEF, now worth US$6.83M, about 6.77% of its recent annual revenue, running through Dec 2026.

Supply contract([Amended] Supply contract signed (voluntary))· FILED 2026-07-16· RCEPT 20260716900127

US$6.83MContract value
6.77%vs. recent revenue
Dec 2026Throughfrom Jul 2026

Converted at 1 USD ≈ ₩1,478.85 (filing-date rate, 2026-07-16 close)

What happened

EuBiologics updated a previously disclosed supply contract with UNICEF, now worth US$6.83M, about 6.77% of its recent annual revenue, running through Dec 2026.

For context, this single contract equals about 6.77% of the company's most recent annual revenue.

CounterpartyUNICEF
Contract valueUS$6.83M
vs. recent revenue6.77%
ThroughDec 2026 (from Jul 2026)
Filed2026-07-16, [Amended] Supply contract signed (voluntary)
SourceDART rcept 20260716900127 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-07-16 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.